Results 41 to 50 of about 28,797 (249)

Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs. [PDF]

open access: yesPLoS ONE, 2014
Epigenetic silencing of tumour suppressor genes has been observed in various cancers. Looking at hepatocellular carcinoma (HCC) specific protein silencing was previously demonstrated to be associated with the Hepatitis C virus (HCV).
Inga Hinrichsen   +6 more
doaj   +1 more source

Regulation of CDK4 [PDF]

open access: yes, 2006
Cyclin-dependent kinase (CDK)4 is a master integrator that couples mitogenic and antimitogenic extracellular signals with the cell cycle. It is also crucial for many oncogenic transformation processes.
Laurence Bockstaele   +4 more
core   +2 more sources

An Opposite Effect of the CDK Inhibitor, p18INK4c on Embryonic Stem Cells Compared with Tumor and Adult Stem Cells [PDF]

open access: yes, 2012
Self-renewal is a feature common to both adult and embryonic stem (ES) cells, as well as tumor stem cells (TSCs). The cyclin-dependent kinase inhibitor, p18INK4c, is a known tumor suppressor that can inhibit self-renewal of tumor cells or adult stem ...
Cindy Tian   +8 more
core   +7 more sources

The effect of resveratrol supplementation on the expression levels of factors associated with cellular senescence and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomised clinical trial

open access: yesBMJ Open, 2019
Introduction Over the past decades, the number of people with type 2 diabetes (T2D) has increased globally. One of the major complications in these patients is cardiovascular disease; it seems that the cell proliferation inhibition can improve vascular ...
Shima Abdollahi   +8 more
doaj   +1 more source

Histopathological characteristics and coexpression of p53 and p16INK4a proteins in renal cancer [PDF]

open access: yesVojnosanitetski Pregled, 2008
Background/Aim. Renal carcinoma represents histologically heterogeneous group of malignant tumors, with various clinical aggressiveness. The frequency of p53 mutation in primal renal carcinoma is rare, although there are information about its ...
Živković Slađana   +3 more
doaj   +1 more source

Genetic Alterations in the INK4a/ARF Locus: Effects on Melanoma Development and Progression

open access: yesBiomolecules, 2020
Genetic alterations in the INK4a/ARF (or CDKN2A) locus have been reported in many cancer types, including melanoma; head and neck squamous cell carcinomas; lung, breast, and pancreatic cancers.
Zizhen Ming, Su Yin Lim, Helen Rizos
doaj   +1 more source

Understanding signaling cascades in melanoma [PDF]

open access: yes, 2008
Understanding regulatory pathways involved in melanoma development and progression has advanced significantly in recent years. It is now appreciated that melanoma is the result of complex changes in multiple signaling pathways that affect growth control,
Akslen L. A.   +58 more
core   +1 more source

Deletion of cyclin dependent kinase inhibitor 2a gene as a marker of oropharyngeal carcinomas non-associated with human papillomavirus and its prognostic value

open access: yesMedičnì Perspektivi
Patients with human papilloma virus associated oropharyngeal squamous cell carcinoma generally have better treatment outcomes and prognosis compared to those with non-papillomavirus-associated oropharyngeal squamous cell carcinoma.
I.S. Shponka   +3 more
doaj   +1 more source

The ING1a tumor suppressor regulates endocytosis to induce cellular senescence via the Rb-E2F pathway. [PDF]

open access: yesPLoS Biology, 2013
The INhibitor of Growth (ING) proteins act as type II tumor suppressors and epigenetic regulators, being stoichiometric members of histone acetyltransferase and histone deacetylase complexes. Expression of the alternatively spliced ING1a tumor suppressor
Uma Karthika Rajarajacholan   +2 more
doaj   +1 more source

Cyclin D activates the Rb tumor suppressor by mono-phosphorylation [PDF]

open access: yes, 2014
The widely accepted model of G1 cell cycle progression proposes that cyclin D:Cdk4/6 inactivates the Rb tumor suppressor during early G1 phase by progressive multi-phosphorylation, termed hypo-phosphorylation, to release E2F transcription factors ...
Choi, Yoon J   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy